Mylan Launches First Adcirca Generic, Stock Moves Up

Mylan Launches First Adcirca Generic, Stock Moves Up

Submitted by admin on August 13, 2018 - 5:56pm
Source: 
Market Realist
News Tags: 
Mylan
tadalafil
generics
PAH
Adcirca
United Therapeutics
Headline: 
Mylan Launches First Adcirca Generic, Stock Moves Up
snippet: 
Today, Mylan Pharmaceuticals (MYL) announced the launch of tadalafil tablets USP (20 mg) in the United States. Tadalafil is intended for the treatment of PAH (pulmonary arterial hypertension) for the improvement of exercise ability.

Do Not Allow Advertisers to Use My Personal information